Hereditary Testing Market by Disease Type (Hereditary Non-cancer Testing, Hereditary Cancer Testing), by Technology (Biochemical, Cytogenic, Molecular Testing), and by Region - Global Forecast to 2023-2033

The hereditary testing market size is estimated to be USD 6,345.1 million in 2022 and is expected to witness a CAGR of 9.51% during the forecast period 2023-2033. Growing field of reproductive genetic health, increase in the demand for newborn screening, and rise in the need for genetic testing are projected to drive the market growth in near future. Furthermore, increasing technological developments and surge in chronic diseases is expected to support the market growth. However, ineffective regulation of the tests is predicted to limit market growth are expected to restrain the market growth.

Increase in the demand for newborn screening is projected to drive the market growth. Continuous growth in the demand for newborn screening has increased the demand for DNA testing kits, which has increased revenues. Newborn screening is becoming more widely used globally, which is helping to boost sales. Multigene panel testing for hereditary cancer has been included into clinical practise as a result of changes to genetic testing recommendations. Information on various cancer risk factors and treatment is available in the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) for breast, ovarian, and colorectal cancers.

Rise in the need for genetic testing anticipated to fuel the market growth. DNA screening kit purchases have surged as a result of the rise in the demand for genetic testing. For instance, in November 2019, the Virginia Department of General Services Division of Integrated Laboratory Facilities examined 7,867 babies for over 31 genetic and metabolic disorders. The market is expanding as newborn screening is being used more often globally. Multigene panel screening has become more prevalent in clinics for inherited disorders due to modifications made to genetic testing protocols.

Segmentation

By Disease Type

The market is categorized into hereditary non-cancer testing and hereditary cancer testing. In 2022, the hereditary cancer testing segment accounted for the highest revenue share. The breast cancer segment dominated the market during the forecast period due to the range of products and services available for various hereditary cancer tests. The market has been substantially fueled by the recent entry of big players including Quest in this area. Companies are emphasizing on business strategies to increase their position in this market as they view breast cancer genetic testing as a valuable source of revenue. Offering hereditary tests for less than competitors charge is one of the approaches. For instance, Color Genomics started selling its products for USD 259, whereas Myriad charged approximately USD 4,000 for comparable items.

By Technology

The market is segmented into biochemical, cytogenic and molecular testing. In the global market, the molecular testing segment accounted for the largest revenue share in 2022 owing to fact that genetic analysis is the most extensively used method for hereditary genetic screening. For instance, carriers testing, medical tests, pre-symptomatic testing, and other procedures all make use of genetic hereditary testing kits. Genetic testing is also preferred as it can be used to study DNA increases and losses that are undetectable by standard chromosomal inspection.

Regional Markets

In 2022, Europe region accounted for the highest revenue in the hereditary testing market and is expected to maintain its dominance during the forecast period. This is attributed to existence of major players offering genetic testing, widespread use of cutting-edge therapies, and recommendations made by government organisations to guarantee the quality of hereditary testing services. The approval and commercialization of tests in the worldwide market have been profoundly impacted by regional variations in regulatory frameworks pertaining to genetic tests. Presently, numerous significant American companies and other countries in Europe, Asia Pacific, and other regions provide a broad range of genetic tests. The all-cash equity acquisition of Blueprint Genetics by diagnostic information services provider Quest Diagnostics was announced in January 2020. Next-generation sequencing (NGS) and proprietary bioinformatics are the main tools used by Blueprint Genetics to interpret gene variants. By making actionable insights into genetic and rare diseases more widely available, Quest and Blueprint Genetics will enhance patient care and pharmaceutical medicine research and development. Such measures can improve the genetic testing situation for inherited disorders in North America, promoting local revenue generation.

Competitor Insights

Some of the key players operating in the hereditary testing market are Laboratory Corporation of America Holdings, Illumina, Inc., Quest Diagnostics Incorporated, CooperSurgical, Inc., F. Hoffmann-La Roche Ltd, Invitae Corporation, Agilent Technologies, Inc., Natera, Inc., Myriad Genetics, Inc., and Thermo Fisher Scientific, Inc.

To achieve a competitive edge, these businesses are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

  • For instance, Natera’s cross-selling initiatives have enabled the business to generate significant revenue throughout the years. The business encourages women who have not had carrier screening tests in their first trimester to use both Horizon and Panorama products.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including disease type and technology from 2022 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 6,345.1 Million
CAGR
  • 9.51%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Disease Type
  • Technology
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Hereditary Testing Market Report 2022 – 2033

Disease Type (Revenue, USD Million), 2022 – 2033

  • Hereditary Non-cancer Testing
    • Genetic Tests
    • Preimplantation Genetic Diagnosis & Screening
    • Newborn Genetic Screening
    • Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
  • Hereditary Cancer Testing
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Ovarian Cancer
    • Melanoma
    • Sarcoma
    • Pancreatic Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Uterine Cancer
    • Gastric Cancer
    • Others

Technology (Revenue, USD Million), 2022 – 2033

  • Biochemical
  • Cytogenic
  • Molecular Testing

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Hereditary Testing Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Hereditary Testing
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Hereditary Testing Market  
  3. Market Analysis by Disease Type
    1. Hereditary Non-cancer Testing
      1. Hereditary Non-cancer Testing Market Forecast, 2022-2033(USD Million)
        1. Genetic Tests
          1. Genetic TestsMarket Forecast, 2022-2033 (USD Million)
        2. Preimplantation Genetic Diagnosis & Screening
          1. Preimplantation Genetic Diagnosis & ScreeningMarket Forecast, 2022-2033 (USD Million)
        3. Newborn Genetic Screening
          1. Newborn Genetic ScreeningMarket Forecast, 2022-2033 (USD Million)
        4. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
          1. Non-invasive Prenatal Testing (NIPT) & Carrier Screening TestsMarket Forecast, 2022-2033 (USD Million)
        5. Hereditary Cancer Testing
          1. Hereditary Cancer Testing Market Forecast, 2022-2033(USD Million)
            1. Breast Cancer
              1. Breast CancerMarket Forecast, 2022-2033 (USD Million)
            2. Lung Cancer
              1. Lung Cancer Market Forecast, 2022-2033(USD Million)
            3. Prostate Cancer
              1. Prostate CancerMarket Forecast, 2022-2033 (USD Million)
            4. Ovarian Cancer
              1. Ovarian Cancer Market Forecast, 2022-2033(USD Million)
            5. Melanoma
              1. MelanomaMarket Forecast, 2022-2033 (USD Million)
            6. Sarcoma
              1. Sarcoma Market Forecast, 2022-2033(USD Million)
            7. Pancreatic Cancer
              1. Pancreatic Cancer Market Forecast, 2022-2033 (USD Million)
            8. Colorectal Cancer
              1. Colorectal Cancer Market Forecast, 2022-2033(USD Million)
            9. Cervical Cancer
              1. Cervical CancerMarket Forecast, 2022-2033 (USD Million)
            10. Uterine Cancer
              1. Uterine Cancer Market Forecast, 2022-2033(USD Million)
            11. Gastric Cancer
              1. Gastric Cancer Market Forecast, 2022-2033 (USD Million)
            12. Others
              1. Others Market Forecast, 2022-2033(USD Million)
  1. Market Analysis byTechnology
    1. Biochemical
      1. Biochemical Market Forecast, 2022-2033(USD Million)
    2. Cytogenic
      1. Cytogenic Market Forecast, 2022-2033(USD Million)
    3. Molecular Testing
      1. Molecular TestingMarket Forecast, 2022-2033 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
  2. North America Hereditary Testing Market  
    1. North America Hereditary Testing Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033(USD Million)
      2. S. Hereditary Testing Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. Canada Hereditary Testing Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033(USD Million)
  1. Europe Hereditary Testing Market  
    1. Europe Hereditary Testing Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033(USD Million)
      2. Germany Hereditary Testing Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. UK Hereditary Testing Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. France Hereditary Testing Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Technology, 2022-2033(USD Million)
            2. Spain Hereditary Testing Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Technology, 2022-2033(USD Million)
              2. Italy Hereditary Testing Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
                  2. Market Size and Forecast by Technology, 2022-2033(USD Million)
                2. Rest of Europe Hereditary Testing Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
                    2. Market Size and Forecast by Technology, 2022-2033(USD Million)
  1. Asia Pacific Hereditary Testing Market  
    1. Asia Pacific Hereditary Testing Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033(USD Million)
      2. Japan Hereditary Testing Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. China Hereditary Testing Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. India Hereditary Testing Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Technology, 2022-2033(USD Million)
            2. South Korea Hereditary Testing Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Technology, 2022-2033(USD Million)
                3. Market Size and Forecast by Device, 2022-2033(USD Million)
              2. Australia Hereditary Testing Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
                  2. Market Size and Forecast by Technology, 2022-2033(USD Million)
                2. Rest of Asia Pacific Hereditary Testing Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
                    2. Market Size and Forecast by Technology, 2022-2033(USD Million)
  1. Latin America Hereditary Testing Market  
    1. Latin America Hereditary Testing Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033(USD Million)
      2. Brazil Hereditary Testing Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. Mexico Hereditary Testing Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. Argentina Hereditary Testing Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Technology, 2022-2033(USD Million)
            2. Rest of Latin America Hereditary Testing Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
                2. Market Size and Forecast by Technology, 2022-2033(USD Million)
  1. MEA Hereditary Testing Market  
    1. MEA Hereditary Testing Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
        2. Market Size and Forecast by Technology, 2022-2033(USD Million)
      2. GCC Hereditary Testing Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
          2. Market Size and Forecast by Technology, 2022-2033(USD Million)
        2. South Africa Hereditary Testing Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
            2. Market Size and Forecast by Technology, 2022-2033(USD Million)
          2. Rest of MEA Hereditary Testing Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease Type, 2022-2033(USD Million)
              2. Market Size and Forecast by Technology, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Laboratory Corporation of America Holdings
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    2. Illumina, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    3. Quest Diagnostics Incorporated
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    4. CooperSurgical, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    5. Hoffmann-La Roche Ltd
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    6. Invitae Corporation
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    7. Agilent Technologies, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    8. Natera, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    9. Myriad Genetics, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    10. Thermo Fisher Scientific, Inc.
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Disease Type Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion & Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.